Trial Profile
A study of subcutaneous R744 in chronic renal failure patients with renal anemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Jun 2016
Price :
$35
*
At a glance
- Drugs Methoxy polyethylene glycol-epoetin beta (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Sponsors Chugai Pharmaceutical
- 01 Jun 2016 New trial record